# FDA Inspection 1021703 - Shilpa Gupta - July 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/shilpa-gupta/79ea99a7-c9ff-4e98-b1f4-58d8c6e539aa
Source feed: FDA_Inspections

> FDA Inspection 1021703 for Shilpa Gupta on July 20, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021703
- Company Name: Shilpa Gupta
- Inspection Date: 2017-07-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1310244 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/shilpa-gupta/d24d37f1-7ee0-4ab9-93c4-cda745251170)

Company: https://www.keypedia.com/companies/shilpa-gupta/393d9806-25b2-4496-a48b-a6cf2804764d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c